The Reovirus Variant RP116 is Oncolytic in Immunocompetent Models and Generates Reduced Neutralizing Antibodies to Type 3 Dearing
MOLECULAR THERAPY ONCOLOGY(2024)
Key words
MT: Regular Issue,reovirus variant,truncated Sigma1,determinant for reovirus oncolysis,ICI combination,reduction of neutralization,sequential tandem therapy
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined